Sex differences in pulmonary arterial hypertension: role of infection and autoimmunity in the pathogenesis of disease
- PMID: 29669571
- PMCID: PMC5907450
- DOI: 10.1186/s13293-018-0176-8
Sex differences in pulmonary arterial hypertension: role of infection and autoimmunity in the pathogenesis of disease
Abstract
Registry data worldwide indicate an overall female predominance for pulmonary arterial hypertension (PAH) of 2-4 over men. Genetic predisposition accounts for only 1-5% of PAH cases, while autoimmune diseases and infections are closely linked to PAH. Idiopathic PAH may include patients with undiagnosed autoimmune diseases based on the relatively high presence of autoantibodies in this group. The two largest PAH registries to date report a sex ratio for autoimmune connective tissue disease-associated PAH of 9:1 female to male, highlighting the need for future studies to analyze subgroup data according to sex. Autoimmune diseases that have been associated with PAH include female-dominant systemic sclerosis, systemic lupus erythematosus, rheumatoid arthritis, Sjögren's syndrome, and thyroiditis as well as male-dominant autoimmune diseases like myocarditis which has been linked to HIV-associated PAH. The sex-specific association of PAH to certain infections and autoimmune diseases suggests that sex hormones and inflammation may play an important role in driving the pathogenesis of disease. However, there is a paucity of data on sex differences in inflammation in PAH, and more research is needed to better understand the pathogenesis underlying PAH in men and women. This review uses data on sex differences in PAH and PAH-associated autoimmune diseases from registries to provide insight into the pathogenesis of disease.
Keywords: Autoimmune disease; Inflammation; Myocarditis; Pulmonary arterial hypertension; Sex differences; Systemic sclerosis.
Conflict of interest statement
Competing interests
The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Figures

Similar articles
-
Sex Dimorphism in Pulmonary Arterial Hypertension Associated With Autoimmune Diseases.Arterioscler Thromb Vasc Biol. 2024 Oct;44(10):2169-2190. doi: 10.1161/ATVBAHA.124.320886. Epub 2024 Aug 15. Arterioscler Thromb Vasc Biol. 2024. PMID: 39145392 Review.
-
[Pulmonary arterial hypertension: a flavor of autoimmunity].Med Sci (Paris). 2013 Jun-Jul;29(6-7):607-16. doi: 10.1051/medsci/2013296013. Epub 2013 Jul 12. Med Sci (Paris). 2013. PMID: 23859515 Review. French.
-
Sex differences in spontaneous versus induced animal models of autoimmunity.Autoimmun Rev. 2012 May;11(6-7):A422-9. doi: 10.1016/j.autrev.2011.11.020. Epub 2011 Dec 4. Autoimmun Rev. 2012. PMID: 22172712 Review.
-
Pulmonary hypertension in rheumatic diseases: epidemiology and pathogenesis.Rheumatol Int. 2013 Jul;33(7):1655-67. doi: 10.1007/s00296-012-2659-y. Epub 2013 Jan 19. Rheumatol Int. 2013. PMID: 23334373 Review.
-
Autoimmunity and pulmonary hypertension: a perspective.Eur Respir J. 2005 Dec;26(6):1110-8. doi: 10.1183/09031936.05.00045705. Eur Respir J. 2005. PMID: 16319344 Review.
Cited by
-
Long noncoding RNA XIST: Mechanisms for X chromosome inactivation, roles in sex-biased diseases, and therapeutic opportunities.Genes Dis. 2022 Apr 29;9(6):1478-1492. doi: 10.1016/j.gendis.2022.04.007. eCollection 2022 Nov. Genes Dis. 2022. PMID: 36157489 Free PMC article. Review.
-
Perillyle alcohol and Quercetin ameliorate monocrotaline-induced pulmonary artery hypertension in rats through PARP1-mediated miR-204 down-regulation and its downstream pathway.BMC Complement Med Ther. 2020 Jul 13;20(1):218. doi: 10.1186/s12906-020-03015-1. BMC Complement Med Ther. 2020. PMID: 32660602 Free PMC article.
-
Systems Analysis of the Human Pulmonary Arterial Hypertension Lung Transcriptome.Am J Respir Cell Mol Biol. 2019 Jun;60(6):637-649. doi: 10.1165/rcmb.2018-0368OC. Am J Respir Cell Mol Biol. 2019. PMID: 30562042 Free PMC article.
-
Mice with humanized immune system as novel models to study HIV-associated pulmonary hypertension.Front Immunol. 2022 Aug 5;13:936164. doi: 10.3389/fimmu.2022.936164. eCollection 2022. Front Immunol. 2022. PMID: 35990658 Free PMC article.
-
Tumor Necrosis Factor Induces Obliterative Pulmonary Vascular Disease in a Novel Model of Connective Tissue Disease-Associated Pulmonary Arterial Hypertension.Arthritis Rheumatol. 2020 Oct;72(10):1759-1770. doi: 10.1002/art.41309. Epub 2020 Aug 20. Arthritis Rheumatol. 2020. PMID: 32388926 Free PMC article.
References
-
- Barst RJ, McGoon M, Torbicki A, Sitbon O, Krowka MJ, Olschewski H, et al. Diagnosis and differential assessment of pulmonary arterial hypertension. J Am Coll Cardiol. 2004;43:S40–SS7. - PubMed
-
- Farber HW, Loscalzo J. Pulmonary arterial hypertension. N Engl J Med. 2004;351:1655–1665. - PubMed
-
- Simonneau G, Gatzoulis MA, Adatia I, Celermajer D, Denton C, Ghofrani A, et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol. 2013;62:D34–D41. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical